#56: Destination Demyelination, Installment #2
Email This Show To A Colleague
Publication Date: Feb 9, 2007.
Show Notes: A laboratory model for Multiple Sclerosis is being used in mice to demonstrate potential therapeutic efficacy of nicotinamide (niacin, vitamin B-3) for multiple sclerosis.
And in our other report, a vaccination against a cytokine may be efficacious against MS. The chemical messenger secreted by a newly discovered type of T-helper cell has been exposed as the ‘root of all inflammatory and autoimmune evils.’ Vaccination against this cytokine presents a potential therapeutic strategy against MS, and a host of other autoimmune - ‘auto-inflammatory’ - disorders.
To provide us with your feedback:
E-mail: feedback@MedicalNewsPodcasts.com;
Call our comment line: 206-202-1043; or
Posted in Destination Demyelination
